Acyl Chain-Dependent Effect of Lysophosphatidylcholine on Endothelium-Dependent Vasorelaxation

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Rao, Shailaja P ^a   Riederer, Monika ^a,c   Lechleitner, Margarete ^a   Hermansson, Martin ^b   Desoye, Gernot ^a   Hallström, Seth ^a   Graier, Wolfgang F ^a   Frank, Saša ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF HELSINKI   (Finland)

^c University of Applied Sciences   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ARACHIDONOYL LYSOPHOSPHATIDYLCHOLINE; CAY 10441; INDOMETACIN; LINOLEOYL LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLCHOLINE; OLEOYL LYSOPHOSPHATIDYLCHOLINE; PALMITOYL LYSOPHOSPHATIDYLCHOLINE; PROSTACYCLIN RECEPTOR; PROSTACYCLIN RECEPTOR SYNTHASE INHIBITOR; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; RECEPTOR BLOCKING AGENT; SUPEROXIDE; TEMPOL; THROMBOXANE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EX VIVO STUDY; MALE; MOUSE; MYOGRAPHY; NONHUMAN; PROSTAGLANDIN RELEASE; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; LYSOPHOSPHATIDYLCHOLINES; MALE; MICE; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RECEPTORS, THROMBOXANE; THROMBOXANE A2; VASODILATION;

EID: 84878574731     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065155     Document Type: Article

References (38)

1. Sato H, Kato R, Isogai Y, Saka G, Ohtsuki M, et al. (2008) Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. Journal of Biological Chemistry 283: 33483-33497.
2. Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT, (2009) Lecithin: cholesterol acyltransferase-from biochemistry to role in cardiovascular disease. Current Opinion in Endocrinology, Diabetes & Obesity 16: 163-171.
3. Parthasarathy S, Steinbrecher UP, Barnett J, Witztum JL, Steinberg D, (1985) Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A 82: 3000-3004.
4. Gauster M, Rechberger G, Sovic A, Horl G, Steyrer E, et al. (2005) Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res 46: 1517-1525.
5. Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, Wagner E, Nong Z, (2004) Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol 24: 1750-1754.
6. Ojala PJ, Hirvonen TE, Hermansson M, Somerharju P, Parkkinen J, (2007) Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J Leukoc Biol 82: 1501-1509.
7. Chen L, Liang B, Froese DE, Liu S, Wong JT, et al. (1997) Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation. J Lipid Res 38: 546-553.
8. Croset M, Brossard N, Polette A, Lagarde M, (2000) Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochemical Journal 345 Pt 1: 61-67.
9. Ojala PJ, Hermansson M, Tolvanen M, Polvinen K, Hirvonen T, et al. (2006) Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. Biochemistry 45: 14021-14031.
10. Zhang R, Bai N, So J, Laher I, MacLeod KM, et al. (2009) The ischemic metabolite lysophosphatidylcholine increases rat coronary arterial tone by endothelium-dependent mechanisms. J Mol Cell Cardiol 47: 112-120.
11. Froese DE, McMaster J, Man RY, Choy PC, Kroeger EA, (1999) Inhibition of endothelium-dependent vascular relaxation by lysophosphatidylcholine: impact of lysophosphatidylcholine on mechanisms involving endothelium-derived nitric oxide and endothelium derived hyperpolarizing factor. Mol Cell Biochem 197: 1-6.
12. Furchgott RF, Vanhoutte PM, (1989) Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018.
13. Wong MS, Vanhoutte PM, (2010) COX-mediated endothelium-dependent contractions: from the past to recent discoveries. Acta Pharmacol Sin 31: 1095-1102.
14. Williams SP, Dorn GW Jr, Rapoport RM, (1994) Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle. Am J Physiol 267: H796-803.
15. Coleman RA, Smith WL, Narumiya S, (1994) International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229.
16. Gluais P, Paysant J, Badier-Commander C, Verbeuren T, Vanhoutte PM, et al. (2006) In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factors. Am J Physiol Heart Circ Physiol 291: H2255-2264.
17. Tang EH, Vanhoutte PM, (2009) Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions. Pharmacol Ther 122: 140-149.
18. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M, (2005) Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146: 834-845.
19. Tang XD, Garcia ML, Heinemann SH, Hoshi T, (2004) Reactive oxygen species impair Slo1 BK channel function by altering cysteine-mediated calcium sensing. Nat Struct Mol Biol 11: 171-178.
20. Rubanyi GM, Vanhoutte PM, (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250: H822-827.
21. Riederer M, Ojala PJ, Hrzenjak A, Graier WF, Malli R, et al. (2010) Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production. J Lipid Res 51: 2957-2966.
22. Dikalov S, Griendling KK, Harrison DG, (2007) Measurement of reactive oxygen species in cardiovascular studies. Hypertension 49: 717-727.
23. Li H, Meininger CJ, Wu G, (2000) Rapid determination of nitrite by reversed-phase high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 746: 199-207.
24. Tang EH, Jensen BL, Skott O, Leung GP, Feletou M, et al. (2008) The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res 78: 130-138.
25. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, et al. (2005) Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 289: H1027-1032.
26. Simonsen U, Christensen FH, Buus NH, (2009) The effect of tempol on endothelium-dependent vasodilatation and blood pressure. Pharmacol Ther 122: 109-124.
27. Hristovska AM, Rasmussen LE, Hansen PB, Nielsen SS, Nusing RM, et al. (2007) Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension 50: 525-530.
28. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M, (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196: 193-222.
29. Tang EH, Ku DD, Tipoe GL, Feletou M, Man RY, et al. (2005) Endothelium-dependent contractions occur in the aorta of wild-type and COX2-/- knockout but not COX1-/- knockout mice. J Cardiovasc Pharmacol 46: 761-765.
30. Feletou M, Verbeuren TJ, Vanhoutte PM, (2009) Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol 156: 563-574.
31. Fujino T, Yuhki K, Yamada T, Hara A, Takahata O, et al. (2002) Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells. Br J Pharmacol 136: 530-539.
32. Liu B, Luo W, Zhang Y, Li H, Zhu N, et al. (2012) Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Exp Physiol 97: 277-289.
33. Wolf A, Saito T, Dudek R, Bing RJ, (1991) The effect of lysophosphatidylcholine on coronary and renal circulation in the rabbit. Lipids 26: 223-226.
34. Menon NK, Bing RJ, (1991) Nitroarginine does not inhibit lysophosphatidylcholine (LPC)-induced vascular relaxation and accumulation of cyclic GMP. Proc Soc Exp Biol Med 196: 461-463.
35. Dudek R, Conforto A, Bing RJ, (1993) Lysophosphatidylcholine-induced vascular relaxation and production of cGMP are mediated by endothelium-derived relaxing factor. Proc Soc Exp Biol Med 203: 474-479.
36. Vuong TD, de Kimpe S, de Roos R, Rabelink TJ, Koomans HA, et al. (2001) Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta. Kidney Int 60: 1088-1096.
37. Brkic L, Riederer M, Graier WF, Malli R, Frank S, (2012) Acyl chain-dependent effect of lysophosphatidylcholine on cyclooxygenase (COX)-2 expression in endothelial cells. Atherosclerosis 224: 348-354.
38. Pluckthun A, Dennis EA, (1982) Acyl and phosphoryl migration in lysophospholipids: importance in phospholipid synthesis and phospholipase specificity. Biochemistry 21: 1743-1750.